Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...
According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...
Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene therapies while helping scientists to streamline quality-control processes with a ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue to witness sequencer throughput expansion with systems like the Illumina ...
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and ...
According to MarketsandMarkets™, the Next-Generation Sequencing Market is projected to grow from about USD 14.94 billion in ...
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation ...
Miami University’s Center for Bioinformatics and Functional Genomics (CBFG) has become one of the first institutions in the region to acquire the PacBio VEGA Benchtop System — a cutting-edge DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results